Colo-rectal Cancer Management - Biological Therapy
Biological therapy causes fewer side effects than chemotherapy drugs.
Cancer cells are different from normal cells. Biological or Targeted therapies make use of this principle to attack
The medications used in this therapy are:
Cetuximab was the first targeted therapy approved for treating
Bevacizumab is another monoclonal antibody, approved for first-line use against metastatic colo
Clinical trials are in progress to study different combinations of chemotherapy agents and targeted therapies.